A Study of TG103 Injection in Type 2 Diabetes Subjects

Clinical trial NCT05348122 · UNKNOWN

Trial details

NCT number: NCT05348122
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2022-06-15
Primary completion: 2023-11-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.